Lexicon Pharma

$2.03 0.00% ($0.00)

Get ready to invest

About Lexicon Pharma

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of treatments for human disease. The Company's drug programs include Sotagliflozin and LX9211. The Company also has a number of additional compounds into various stages of clinical and preclinical development. The Company’s LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company intends to initiate a Phase IIa clinical trial evaluating the safety and tolerability of LX9211 and its effects on diabetic peripheral neuropathic (DPN) pain. Its Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of type I diabetes and type II diabetes, heart failure and chronic kidney disease.

Popular Stocks	Price	Change
Southwestern Energy SWN	$7.01 7.35%	7.35%
AMC AMC	$12.47 3.49%	3.49%
AMD AMD	$87.08 5.64%	5.64%
SoFi Technologies, Inc. SOFI	$6.13 6.06%	6.06%
ContextLogic WISH	$1.95 2.99%	2.99%
Bank of America BAC	$32.31 0.72%	0.72%
Apple AAPL	$141.66 2.45%	2.45%
Carnival CCL	$10.85 12.44%	12.44%
Amazon AMZN	$116.46 3.58%	3.58%
Ginkgo Bioworks Holdings DNA	$2.86 2.72%	2.72%